The Journal of pharmacology and experimental therapeutics, 08/2017, Volume 362, Issue 2, p. 296
GW405833, widely accepted as a cannabinoid receptor 2 (CB ) agonist, suppresses pathologic pain in preclinical models without the unwanted central side effects...
Receptor, Cannabinoid, CB2 - agonists | Mice, Inbred C57BL | Neuralgia - metabolism | Morpholines - pharmacology | Male | Pain Measurement - drug effects | Cannabinoid Receptor Agonists - pharmacology | Neuralgia - drug therapy | Mice, Knockout | Dose-Response Relationship, Drug | Inflammation - metabolism | Pain Measurement - methods | Animals | Receptor, Cannabinoid, CB1 - agonists | Inflammation - drug therapy | Cannabinoid Receptor Agonists - therapeutic use | Female | Indoles - pharmacology | Indoles - therapeutic use | Mice | Receptor, Cannabinoid, CB1 - deficiency | Morpholines - therapeutic use | Receptor, Cannabinoid, CB2 - deficiency
Receptor, Cannabinoid, CB2 - agonists | Mice, Inbred C57BL | Neuralgia - metabolism | Morpholines - pharmacology | Male | Pain Measurement - drug effects | Cannabinoid Receptor Agonists - pharmacology | Neuralgia - drug therapy | Mice, Knockout | Dose-Response Relationship, Drug | Inflammation - metabolism | Pain Measurement - methods | Animals | Receptor, Cannabinoid, CB1 - agonists | Inflammation - drug therapy | Cannabinoid Receptor Agonists - therapeutic use | Female | Indoles - pharmacology | Indoles - therapeutic use | Mice | Receptor, Cannabinoid, CB1 - deficiency | Morpholines - therapeutic use | Receptor, Cannabinoid, CB2 - deficiency
Journal Article
Geochimica et Cosmochimica Acta, ISSN 0016-7037, 09/2015, Volume 164, pp. 236 - 261
The impact hypothesis for the origin of CB chondrites was tested by performing equilibrium condensation calculations in systems composed of vaporized mixtures...
HAMMADAH AL HAMRA-237 | GEOCHEMISTRY & GEOPHYSICS | ORIGIN | ZONED METAL | CH CHONDRITES | SOLAR | CONSTRAINTS | SIDEROPHILE ELEMENTS | DISK | CR CHONDRITES | BENCUBBIN | Earth | Meteorites | Silicates | Mantle | Analysis | Alloys
HAMMADAH AL HAMRA-237 | GEOCHEMISTRY & GEOPHYSICS | ORIGIN | ZONED METAL | CH CHONDRITES | SOLAR | CONSTRAINTS | SIDEROPHILE ELEMENTS | DISK | CR CHONDRITES | BENCUBBIN | Earth | Meteorites | Silicates | Mantle | Analysis | Alloys
Journal Article
Blood, ISSN 0006-4971, 11/2010, Volume 116, Issue 21, pp. 3549 - 3549
Abstract Abstract 3549 Cord blood potency is important for transplantation product selection, and various tests have been proposed to measure potency and...
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 11/2016, Volume 139, Issue 3, pp. 396 - 407
Cannabinoid receptor interacting protein 1a (CRIP1a) is a CB sub(1) receptor (CB sub(1)R) distal C-terminus-associated protein that modulates CB sub(1)R...
Journal Article
Neuron, ISSN 0896-6273, 09/2016, Volume 91, Issue 6, pp. 1244 - 1252
Journal Article
Molecular Biology of the Cell, ISSN 1059-1524, 2001, Volume 12, Issue 3, pp. 565 - 576
Interactions between Cajal bodies (CBs) and replication-dependent histone loci occur more frequently than for other mRNA-encoding genes, but such interactions...
XENOPUS GERMINAL VESICLE | COILED BODIES | LAMPBRUSH CHROMOSOMES | SPHERE LOCI | MESSENGER-RNA | HELA-CELLS | SMALL NUCLEAR-RNA | INTERVENING SEQUENCES | BINDING-PROTEIN | CELL-CYCLE | CELL BIOLOGY | Coiled Bodies - genetics | Gene Expression | Humans | RNA, Messenger - genetics | In Situ Hybridization, Fluorescence | RNA, Messenger - metabolism | Genetic Variation | Histones - genetics | RNA, Small Nuclear - genetics | Cell Division | Coiled Bodies - metabolism | HeLa Cells | RNA, Small Nuclear - metabolism
XENOPUS GERMINAL VESICLE | COILED BODIES | LAMPBRUSH CHROMOSOMES | SPHERE LOCI | MESSENGER-RNA | HELA-CELLS | SMALL NUCLEAR-RNA | INTERVENING SEQUENCES | BINDING-PROTEIN | CELL-CYCLE | CELL BIOLOGY | Coiled Bodies - genetics | Gene Expression | Humans | RNA, Messenger - genetics | In Situ Hybridization, Fluorescence | RNA, Messenger - metabolism | Genetic Variation | Histones - genetics | RNA, Small Nuclear - genetics | Cell Division | Coiled Bodies - metabolism | HeLa Cells | RNA, Small Nuclear - metabolism
Journal Article
Journal of neurochemistry, 11/2016, Volume 139, Issue 3, p. 396
Cannabinoid receptor interacting protein 1a (CRIP1a) is a CB receptor (CB R) distal C-terminus-associated protein that modulates CB R signaling via G proteins,...
Cell Line | Morpholines - pharmacology | Gene Dosage | Signal Transduction - genetics | Gene Knockdown Techniques | Naphthalenes - pharmacology | Protein Transport | Carrier Proteins - genetics | Receptor, Cannabinoid, CB1 - metabolism | Endocannabinoids - physiology | Animals | Carrier Proteins - metabolism | Receptor, Cannabinoid, CB1 - agonists | Receptor, Cannabinoid, CB1 - genetics | Piperidines - pharmacology | Receptors, Cell Surface - drug effects | Rimonabant | Benzoxazines - pharmacology | Cell Membrane - metabolism | Mice | RNA, Small Interfering | Cyclohexanols - pharmacology | Pyrazoles - pharmacology
Cell Line | Morpholines - pharmacology | Gene Dosage | Signal Transduction - genetics | Gene Knockdown Techniques | Naphthalenes - pharmacology | Protein Transport | Carrier Proteins - genetics | Receptor, Cannabinoid, CB1 - metabolism | Endocannabinoids - physiology | Animals | Carrier Proteins - metabolism | Receptor, Cannabinoid, CB1 - agonists | Receptor, Cannabinoid, CB1 - genetics | Piperidines - pharmacology | Receptors, Cell Surface - drug effects | Rimonabant | Benzoxazines - pharmacology | Cell Membrane - metabolism | Mice | RNA, Small Interfering | Cyclohexanols - pharmacology | Pyrazoles - pharmacology
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 02/2010, Volume 159, Issue 3, pp. 534 - 542
Journal Article
Science (Washington), ISSN 0036-8075, 10/2005, Volume 310, Issue 5746, pp. 329 - 332
The presence and function of CB sub(2) receptors in central nervous system (CNS) neurons are controversial. We report the expression of CB sub(2) receptor...
Journal Article
Current medicinal chemistry, 2010, Volume 17, Issue 14, p. 1382
CB1 receptors are G-protein coupled receptors (GPCRs) abundant in neurons, in which they modulate neurotransmission. The CB(1) receptor influence on memory and...
Receptor, Cannabinoid, CB1 - metabolism | Calcium Channels - metabolism | Receptors, G-Protein-Coupled - metabolism | Signal Transduction | Vesicular Transport Proteins - metabolism | Adenylyl Cyclases - metabolism | Nitric Oxide - metabolism | Arrestins - metabolism | Adaptor Protein Complex 3 - metabolism | Mitogen-Activated Protein Kinases - metabolism
Receptor, Cannabinoid, CB1 - metabolism | Calcium Channels - metabolism | Receptors, G-Protein-Coupled - metabolism | Signal Transduction | Vesicular Transport Proteins - metabolism | Adenylyl Cyclases - metabolism | Nitric Oxide - metabolism | Arrestins - metabolism | Adaptor Protein Complex 3 - metabolism | Mitogen-Activated Protein Kinases - metabolism
Journal Article
Molecular Pain, ISSN 1744-8069, 5/2016, Volume 12, p. 174480691664919
Fatty-acid amide hydrolase (FAAH) is the major enzyme responsible for degradation of anandamide, an endocannabinoid. Pharmacological inhibition or genetic...
endovanilloid | Fatty-acid amide hydrolase | endocannabinoid | receptor | capsaicin | FAAH knockout | cannabinoid CB | TRPV1 | anandamide | PROTEIN-KINASE-C | INHIBITOR URB597 | MEDIATE | NEUROSCIENCES | cannabinoid CB1 receptor | NEUROPATHIC PAIN | ACTIVATED-RECEPTOR-ALPHA | CANNABINOID RECEPTOR | ENDOCANNABINOIDS | VANILLOID RECEPTORS | ANALGESIA | Inflammation - pathology | Arachidonic Acid - metabolism | Pyrazoles - therapeutic use | Skin - metabolism | Formaldehyde | Capsaicin - administration & dosage | Hyperalgesia - pathology | Inflammation - complications | TRPV Cation Channels - metabolism | Pain - complications | Piperidines - pharmacology | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Inflammation - drug therapy | Pain - drug therapy | TRPV Cation Channels - antagonists & inhibitors | Nociception - drug effects | Pain Threshold - drug effects | Amidohydrolases - deficiency | Acrylamides - pharmacology | Disease Models, Animal | Pyrazoles - pharmacology | Amidohydrolases - metabolism | Lumbar Vertebrae - metabolism | Hyperalgesia - complications | Mice, Inbred C57BL | Injections, Intraperitoneal | Proto-Oncogene Proteins c-fos - metabolism | Genotype | Pain - pathology | Mice, Knockout | Analgesia | Receptor, Cannabinoid, CB1 - metabolism | Spinal Cord Dorsal Horn - drug effects | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Phenotype | Animals | Spinal Cord Dorsal Horn - pathology | Hyperalgesia - drug therapy | Ethanolamines - metabolism | Piperidines - therapeutic use | Ligands | Acrylamides - therapeutic use | Lumbar Vertebrae - pathology | Carrageenan | Receptor, Cannabinoid, CB1 - antagonists & inhibitors
endovanilloid | Fatty-acid amide hydrolase | endocannabinoid | receptor | capsaicin | FAAH knockout | cannabinoid CB | TRPV1 | anandamide | PROTEIN-KINASE-C | INHIBITOR URB597 | MEDIATE | NEUROSCIENCES | cannabinoid CB1 receptor | NEUROPATHIC PAIN | ACTIVATED-RECEPTOR-ALPHA | CANNABINOID RECEPTOR | ENDOCANNABINOIDS | VANILLOID RECEPTORS | ANALGESIA | Inflammation - pathology | Arachidonic Acid - metabolism | Pyrazoles - therapeutic use | Skin - metabolism | Formaldehyde | Capsaicin - administration & dosage | Hyperalgesia - pathology | Inflammation - complications | TRPV Cation Channels - metabolism | Pain - complications | Piperidines - pharmacology | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Inflammation - drug therapy | Pain - drug therapy | TRPV Cation Channels - antagonists & inhibitors | Nociception - drug effects | Pain Threshold - drug effects | Amidohydrolases - deficiency | Acrylamides - pharmacology | Disease Models, Animal | Pyrazoles - pharmacology | Amidohydrolases - metabolism | Lumbar Vertebrae - metabolism | Hyperalgesia - complications | Mice, Inbred C57BL | Injections, Intraperitoneal | Proto-Oncogene Proteins c-fos - metabolism | Genotype | Pain - pathology | Mice, Knockout | Analgesia | Receptor, Cannabinoid, CB1 - metabolism | Spinal Cord Dorsal Horn - drug effects | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Phenotype | Animals | Spinal Cord Dorsal Horn - pathology | Hyperalgesia - drug therapy | Ethanolamines - metabolism | Piperidines - therapeutic use | Ligands | Acrylamides - therapeutic use | Lumbar Vertebrae - pathology | Carrageenan | Receptor, Cannabinoid, CB1 - antagonists & inhibitors
Journal Article
Astrophysical Journal Letters, ISSN 2041-8205, 10/2017, Volume 848, Issue 2, p. L12
On 2017 August 17 a binary neutron star coalescence candidate (later designated GW170817) with merger time 12:41:04 UTC was observed through gravitational...
OPTICAL AFTERGLOWS | NEARBY SUPERNOVA RATES | GRAVITATIONAL-WAVES | PULSAR PSR-1913+16 | COMPACT OBJECTS | gravitational waves | RADIO TELESCOPE | CLOSE BINARIES | GAMMA-RAY BURSTS | stars: neutron | RELATIVISTIC GRAVITY | BLACK-HOLES | Stars: neutron | Gravitational waves | GAMMA-RAY BURST | AFTERGLOW | PULSAR | EVOLUTION | ASTRONOMY & ASTROPHYSICS | REDSHIFT | IMAGER | NUCLEOSYNTHESIS | HOST GALAXY | AstrofÃsica | Astrophysics | Ones gravitacionals | Astronomia i astrofÃsica | Astronomia | Raigs gamma | Astronomy | Àrees temà tiques de la UPC | FÃsica | Gamma ray astronomy | ASTRONOMY AND ASTROPHYSICS | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences
OPTICAL AFTERGLOWS | NEARBY SUPERNOVA RATES | GRAVITATIONAL-WAVES | PULSAR PSR-1913+16 | COMPACT OBJECTS | gravitational waves | RADIO TELESCOPE | CLOSE BINARIES | GAMMA-RAY BURSTS | stars: neutron | RELATIVISTIC GRAVITY | BLACK-HOLES | Stars: neutron | Gravitational waves | GAMMA-RAY BURST | AFTERGLOW | PULSAR | EVOLUTION | ASTRONOMY & ASTROPHYSICS | REDSHIFT | IMAGER | NUCLEOSYNTHESIS | HOST GALAXY | AstrofÃsica | Astrophysics | Ones gravitacionals | Astronomia i astrofÃsica | Astronomia | Raigs gamma | Astronomy | Àrees temà tiques de la UPC | FÃsica | Gamma ray astronomy | ASTRONOMY AND ASTROPHYSICS | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences
Journal Article
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 01/2019, Volume 321, Issue 1, pp. 69 - 79
IMPORTANCE Type 2 diabetes is associated with increased cardiovascular (CV) risk. Prior trials have demonstrated CV safety of 3 dipeptidyl peptidase 4 (DPP-4)...
KIDNEY-DISEASE | MORTALITY | GFR DECLINE | END-POINT | SAXAGLIPTIN | HEART-FAILURE | SITAGLIPTIN | DEATH | OUTCOMES | CKD | MEDICINE, GENERAL & INTERNAL | Type 2 diabetes | Usage | Clinical trials | Research | Risk factors | Complications and side effects | Analysis | Placebos | Linagliptin | Dosage and administration | Kidney diseases | Cardiovascular diseases | Drug therapy | Myocardial infarction | End-stage renal disease | Adjudication | Risk | Effects | Incidence | Randomization | Vascular diseases | Safety engineering | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Peptidase | Epidermal growth factor receptors | Diabetes mellitus | Pancreatitis | Health risks | Hypoglycemia | Insulin | Patients | Placebo effect | Prescription drugs | Renal failure | Infarction | Adults | Diabetes | Online First | Original Investigation
KIDNEY-DISEASE | MORTALITY | GFR DECLINE | END-POINT | SAXAGLIPTIN | HEART-FAILURE | SITAGLIPTIN | DEATH | OUTCOMES | CKD | MEDICINE, GENERAL & INTERNAL | Type 2 diabetes | Usage | Clinical trials | Research | Risk factors | Complications and side effects | Analysis | Placebos | Linagliptin | Dosage and administration | Kidney diseases | Cardiovascular diseases | Drug therapy | Myocardial infarction | End-stage renal disease | Adjudication | Risk | Effects | Incidence | Randomization | Vascular diseases | Safety engineering | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Peptidase | Epidermal growth factor receptors | Diabetes mellitus | Pancreatitis | Health risks | Hypoglycemia | Insulin | Patients | Placebo effect | Prescription drugs | Renal failure | Infarction | Adults | Diabetes | Online First | Original Investigation
Journal Article